|[March 24, 2014]
Exactech Knee, Hip and Shoulder Innovations Presented at the 2014 Orthopaedic Research Society Annual Meeting
GAINESVILLE, Fla. --(Business Wire)--
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and
joint restoration products for hip, knee, shoulder, spine and biologic
materials, presented scientific posters and presentations regarding its
latest advancements for shoulder and knee replacement surgery during the
2014 Orthopaedic Research Society annual meeting in New Orleans.
Four posters presented Exactech's Optetrak Logic® knee
systems as well as the ExactechGPS®, a novel
computer-assisted guidance system for total knee arthroplasty:
Angibaud, L. et al. Accuracy of a Novel Computer-Assisted Guided
System for Total Knee Arthroplasty. Trans. of the 60th
Annual ORS Meeting, Poster #0968, 2014.
Angibaud, L. et al. Evaluation of the Alignment Discrepancies during
Total Knee Arthroplasty Using an Image-free Computer-assisted Guidance
System. Trans. of the 60th Annual ORS Meeting, Poster
Gao, B. et al. Rotational Constraint Comparison between Two TKA
Prostheses - Evaluation Using Computer Simulation. Trans. of the 60th
Annual ORS Meeting, Poster #0973, 2014.
Gardner, A. et al. Unicondylar Wear Test without Cruciate Ligament
Resistance. Trans. of the 60th Annual ORS Meeting, Poster
One poster detailed the impingement performance of Exactech's Connexion
GXL® acetabular liners:
Loftus, E. Impingement Performance of a Moderately Cross-Linked UHMWPE
Liner. Trans. of the 60th Annual ORS Meeting, Poster #1783,
Additionally, six posters presented the biomechanical advantages of
Exactech's Equinoxe® shoulder system, the fastest growing
shoulder replacement system in the U.S.:
Roche, C. et al. Comparison of Bone Removed with Reverse Total
Shoulder Arthroplasty. Trans. of the 60th Annual ORS
Meeting, Poster #1894, 2014.
Flurin, PH. et al. A Comparison and Correlation of Clinical Outcome
Metrics in Anatomic and Reverse Total Shoulder Arthroplasty. Trans. of
the 60th Anual ORS Meeting, Poster #0992, 2014.
Jacobson, A. et al. Humeral Anatomy Study: A Comparison of Male and
Female Shoulders with Similar Average Age and BMI. Trans. of the 60th
Annual ORS Meeting, Poster #0997, 2014.
Roche, C. et al. Restoring Rotator Cuff Muscle Tension in Patients
with Posterior Glenoid Wear using Total Shoulder Arthroplasty. Trans.
of the 60th Annual ORS Meeting, Poster # 0534, 2014.
Roche, C. et al. Reverse Shoulder Glenoid Baseplate Fixation: A
Comparison of Flat-Back vs Curve-Back Designs and Oval vs Round
Designs with 2 Different Offset Glenospheres. Trans. of the 60th
Annual ORS Meeting, Poster #0956, 2014.
Greene, A. et al. Scapula Anatomy Study with Consideration to Reverse
Shoulder Arthroplasty Biomechanics and Design. Trans. of the 60th
Annual ORS Meeting, Poster #0999, 2014.
Based in Gainesville, Fla., Exactech develops and markets orthopaedic
implant devices, related surgical instruments and biologic materials and
services to hospitals and physicians. The company manufactures many of
its orthopaedic devices at its Gainesville facility. Exactech's
orthopaedic products are used in the restoration of bones and joints
that have deteriorated as a result of injury or diseases such as
arthritis. Exactech markets its products in the United States, in
addition to more than 30 markets in Europe, Latin America, Asia and the
Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com.
Copies of Exactech's press releases, SEC (News - Alert) filings, current price quotes
and other valuable information for investors may be found at http://www.exac.com
An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm.
To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of
the Securities Exchange Act of 1934, which represent the company's
expectations or beliefs concerning future events of the company's
financial performance. These forward-looking statements are further
qualified by important factors that could cause actual results to differ
materially from those in the forward-looking statements. These factors
include the effect of competitive pricing, the company's dependence on
the ability of third party manufacturers to produce components on a
basis which is cost-effective to the company, market acceptance of the
company's products and the effects of government regulation. Results
actually achieved may differ materially from expected results included
in these statements.
[ Back To TMCnet.com's Homepage ]